First Trust NYSE Arca Biotechnology Index Fund (FBT)

158.91
Delayed Data
As of Nov 29
 +0.17 / +0.11%
Today’s Change
154.29
Today|||52-Week Range
186.51
-5.41%
Year-to-Date

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology IndexSM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.

Performance

1 month-4.15% 3 years+5.00%
3 months-8.00% 5 years+9.76%
1 year-0.47% Since inception+14.45%
Data through 11/27/2021

Quote Details

Previous close$158.74
Open day’s range158.91 – 161.30
Net asset value (NAV)158.47 (11/26/2021)
Daily volume37,093
Average volume (3 months)38,569
Data as of 3:59pm ET, 11/29/2021

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+9.76%+13.75%
Expense Gross exp ratio0.55%1.00%
Risk 5 year sharpe ratio0.650.91
Net assets$1.8B$2.4B
Average market cap$15.0B$37.7B
Average P/E25.525.0
Dividend / Share--0.29%

Competitors

RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
REGN Regeneron Pharmaceuticals3.82%
BNTX BioNTech SE3.72%
BLUE bluebird bio Inc3.70%
CRL Charles River Laboratories International Inc3.67%
-- 3.57%
MRNA Moderna Inc3.52%
TECH Bio-Techne Corp3.48%
IQV IQVIA Holdings Inc3.47%
RARE Ultragenyx Pharmaceutical Inc3.47%
BMRN Biomarin Pharmaceutical Inc3.45%